RDY

#846
Dr. Reddy's Laboratories Limited American Depositary Shares
13.14 USD
-0.76%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
13.11
13.19
Rango anual
12.81
16.16
Cambio diario
-0.76%
Variación mensual
-6.21%
Variación en los últimos 6 meses
-5.94%
Cambio anual
-1.50%
Cierres anteriores
13.24
Abrir
13.18
Bid
Ask
Mínimo
13.11
High
13.19
Volumen
650
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 10.96 B
  • Employee 28 K
  • Founded 1984
  • CEO Erez Israeli
  • Website www.drreddys.com
  • Headquarter India
  • FIGI BBG000NJ96L6
  • Industry Technology
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr.

Noticias